SAN DIEGO, Oct. 24, 2025 /PRNewswire/ — ChemDiv today announced the extension of its discovery and early development partnership with Mondego Bio to advance the company’s best-in-class immuno-oncology program targeting PTPN2. The announcement follows Mondego Bio’s successful Series A…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
